Human Fibrinogen Concentrate

Fibryga® is a highly purified and pathogen inactivated human fibrinogen concentrate and an effective and convenient treatment for fibrinogen deficiency.

Fibryga® offers a number of benefits: concentration is standardised; it is stable at room temperature, can be reconstituted within minutes, and has a low infusion volume; there is no need for thawing or cross-matching blood type and it is double pathogen inactivated.

  • Treatment of bleeding and perioperative prophylaxis in patients with congenital hypo or afibrinogenaemia with bleeding tendency.1-3

  • Complementary therapy in the treatment of uncontrolled severe haemorrhage in patients with acquired fibrinogen deficiency.4


Fibryga® is presented in vials containing 1 g of fibrinogen as lyophilised powder for reconstitution with 50 mL sterile water for injection (WFI).1

After reconstitution, the solution provides approximately 20 mg/mL of human fibrinogen.

For intravenous administration via infusion or injection.

Do not store above 25 °C. Do not freeze. Keep the bottle in the outer carton to protect from light. The shelf life is two years at room temperature.


1.     Fibryga® - Summary of Product Characteristics (EU)
2.    Fibryga® - US PIL
3.    Fibryga® - Canada monograph
4.    Fibryga® - Summary of Product Characteristics (Switzerland)

Instructions for the reconstitution of fibryga®

You are now on Octapharma’s global website. Please select your country from the menu at the top of this page to access more detailed country-specific information or to contact your local Octapharma team.

Drug safety related information, such as adverse reactions, should be reported to